Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 268,524Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Sanofi

02 1Biophore India Pharmaceuticals Pvt Ltd

03 2Dr. Reddy's Laboratories

04 1NanoAlvand

05 1Supriya Lifescience

06 1Naprod Life Sciences

07 1Accord healthcare

08 1Amneal Pharmaceuticals

09 2Arrotex Pharmaceuticals

10 1Aurobindo Pharma Limited

11 2EUGIA PHARMA (AUSTRALIA) PTY LTD

12 1EUGIA PHARMA INC.

13 1GLAND PHARMA LIMITED

14 1Hetero Drugs

15 1JAMP PHARMA

16 1MSN Laboratories

17 1Meitheal Pharmaceuticals

18 1ORIFARM GROUP AS

19 1SEACROSS PHARMACEUTICALS

20 1Teva Pharmaceutical Industries

21 1Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : RX

Registration Country : USA

PLERIXAFOR

Brand Name : MOZOBIL

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Packaging :

Approval Date : 2008-12-15

Application Number : 22311

Regulatory Info : RX

Registration Country : USA

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Regulatory Info :

Registration Country : India

Jm 3100

Brand Name :

Dosage Form : Injection

Dosage Strength : 24MG/1.2ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Biophore

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Packaging :

Approval Date : 2023-07-24

Application Number : 205182

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

04

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Plerixafor

Brand Name : Neofor

Dosage Form : Vial

Dosage Strength : 24MG/1.2ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Regulatory Info :

Registration Country : India

Plerixafor

Brand Name :

Dosage Form : Injection

Dosage Strength : 24MG/1.2ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Supriya

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNaprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.

Regulatory Info :

Registration Country : India

Plerixafor

Brand Name :

Dosage Form : Liquid Injection

Dosage Strength : 20MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Naprod Life Sciences

07

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Sweden

plerixafor

Brand Name : Mozobil

Dosage Form : INJEKTIONSVÄTSKA, LÖSNING

Dosage Strength : 20 MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Sanofi Company Banner

08

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Jm 3100

Brand Name : Mozobil

Dosage Form : Plerixafor 24Mg 1,2Ml 1 Unit Parenteral Use

Dosage Strength : 1 bottle SC 24 mg 20 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

09

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Jm 3100

Brand Name : Mozobil

Dosage Form : Injection fluid, resolution

Dosage Strength : 20 mg/ml

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

10

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

PLERIXAFOR

Brand Name : MOZOBIL

Dosage Form : SOLUTION

Dosage Strength : 20MG/ML

Packaging : 1.2ML

Approval Date :

Application Number : 2377225

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner

11

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Plerixafor

Brand Name : Mozobil

Dosage Form : INJ

Dosage Strength : 20mg/ml

Packaging : 1.2X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

12

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Australia

plerixafor

Brand Name : Mozobil

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Sanofi Company Banner

13

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Australia

plerixafor

Brand Name : Mozobil

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Sanofi Company Banner

14

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Plerixafor

Brand Name :

Dosage Form : Injection

Dosage Strength : 20MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Dr Reddy Company Banner

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Packaging :

Approval Date : 2023-07-24

Application Number : 215334

Regulatory Info : RX

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Packaging :

Approval Date : 2023-07-24

Application Number : 213672

Regulatory Info : RX

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Packaging :

Approval Date : 2024-05-03

Application Number : 206644

Regulatory Info : RX

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Packaging :

Approval Date : 2023-07-24

Application Number : 211901

Regulatory Info : RX

Registration Country : USA

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Packaging :

Approval Date : 2023-07-24

Application Number : 205197

Regulatory Info : RX

Registration Country : USA

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Packaging :

Approval Date : 2023-07-26

Application Number : 208980

Regulatory Info : DISCN

Registration Country : USA

blank